TNF, TNF inducers and TNFR2 agonists: A new path to type 1 diabetes treatment
Diabetes/Metabolism Research and Reviews Aug 30, 2017
Faustman DL – Keeping the objective in mind, researchers demonstrated that the advancing global clinical trials applying BCG combined with mechanistic data on BCGs induction of Tregs suggests value in this generic drug and possible immune reversal of the type 1 diabetic autoimmune process.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
